The mid-cycle transition de-rating is advanced but unfinished. Falling earnings revision breadth this fall will likely complete that process. We like a barbell of defensives (h/c and staples) and rate plays (financials) as Fed moves toward tapering. Weak breadth reflects De-rating under the surface. Our mid cycle transition continues with weak breadth, quality stocks doing better and an overall de-rating…
Morgan Stanley Downgrades Energy To Underweight: Mid-cycle Transition Continues
A financial market resource for the every-day investor and trader.
-
Will Markets Crack Under The Pressure of COVID?
Seth Golden, , Research Reports, 0
Has the COVID-19 reemerging positive case ratio finally caught up to what many have described as a market that...
-
Haven’t Broken The Bear’s Back… Yet
Seth Golden, , Research Reports, 0
I’ll be flying solo for this weekend’s Research Report, as Edward is off this weekend. So forgive any shortcomings...
-
Are Investors Living On the Edge Right Now?
Seth Golden, , Research Reports, 0
Let’s get this party started folks! If last week the market proved one thing it is this: Buying begets...
-
Another 10% Correction Morgan Stanley Believes Lay Ahead
Seth Golden, , Research Reports, 0
Weekly Warm-up: ResistanceHolds; Earnings Upside vsMultiple for Stock Selection Last week’s failure to break through technical resistance for second...
-
Geopolitical Concerns Weigh Heavily Against Earnings Season
Seth Golden, , Research Reports, 2
Words carry meaning! As an investor, when contemplating those words in the geopolitical and macro realm, deciphering words and...
-
J.P. Morgan Equity Strategy Update Q1 2021
Seth Golden, , Research Reports, 0
Equity Strategy Market Update, Style Positioning − Where does the Momentum Unwind stand? The recent market volatility has been...
-
-
Weekly State of the Market: Macro-Market Winds
Seth Golden, , Research Reports, 0
Yield curve is the most inverted in decades, yet many parts of the market are making new 52-week highs....
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00